Sandu Brhat Shwas Kas Chintamani Ras | Strengthens & Rejuvenates Respiratory Health | 20 Tabs – Fast UK Delivery
- Manufactured by Sandu Pharmaceuticals Ltd, Sandu Brhat Shwas Kasa Chintamani Ras tablets are a distinguished Ayurvedic formulation crafted to support and fortify the respiratory system.
- Key ingredients include Yashtimadhu (Glycyrrhiza glabra), Kantakari (Solanum xanthocarpum), Tambul (Piper betel), as well as precious elements such as Gold, Mica, Pearl, and Copper pyrite.
- Suggested usage: Take one tablet (125 mg) three to four times per day.
- Trusted Quality: Sandu is an ISO 9001:2000 certified company, committed to maintaining the highest standards in the selection of packageing materials. To prevent any interaction between the medicine and its container, we exclusively use glass bottles for packageing Asav, Arishta, and Kadha, thereby preserving the purity, potency, and efficacy of our products.
Free Delivery on 3 Quantities or 3 Products
Delivered in 8–17 days
Delivered in 8-17 days
No Customs Duty, No Hidden Charges (DDP)
🎉 First Order? Use code WELCOME10 and get up to 10% OFF.
Free Delivery on 3 Quantities or 3 Products
Delivered in 8-17 days
Get $5 off purchases of $60 or more — enter coupon code ('XMAX2025' ) at checkout.
Every order includes a FREE surprise Christmas gift...
Get 7% OFF on all future orders for 1 year — Christmas offer, today only!
Order help?
Connect with us on WhatsApp – personal support, not a chatbot.
Guaranteed Safe Checkout
Features & Compatibility
Sandu Brhat Shwas Kasa Chintamani Ras is a remarkable Ayurvedic formulation crafted to bolster respiratory health. It helps prevent frequent respiratory ailments and strengthens the heart, making it especially useful for asthma cases associated with cardiac complications. Furthermore, it prolongs the duration of wellness between successive asthma attacks.
Additional information
| Ship to countries |
United Kingdom |
|---|---|
| Brand |
SANDU |
| Sold By |
Yamuna Desi Store |
| weight |
20 g |
Reviews
There are no reviews yet.